These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

358 related articles for article (PubMed ID: 7527328)

  • 1. Lacidipine. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic potential in the treatment of hypertension.
    Lee CR; Bryson HM
    Drugs; 1994 Aug; 48(2):274-96. PubMed ID: 7527328
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lacidipine: a review of its use in the management of hypertension.
    McCormack PL; Wagstaff AJ
    Drugs; 2003; 63(21):2327-56. PubMed ID: 14524737
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lercanidipine : a review of its efficacy in the management of hypertension.
    Bang LM; Chapman TM; Goa KL
    Drugs; 2003; 63(22):2449-72. PubMed ID: 14609358
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Calcium antagonist lacidipine slows down progression of asymptomatic carotid atherosclerosis: principal results of the European Lacidipine Study on Atherosclerosis (ELSA), a randomized, double-blind, long-term trial.
    Zanchetti A; Bond MG; Hennig M; Neiss A; Mancia G; Dal Palù C; Hansson L; Magnani B; Rahn KH; Reid JL; Rodicio J; Safar M; Eckes L; Rizzini P;
    Circulation; 2002 Nov; 106(19):2422-7. PubMed ID: 12417537
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Manidipine: a review of its use in hypertension.
    Cheer SM; McClellan K
    Drugs; 2001; 61(12):1777-99. PubMed ID: 11693466
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical position of lacidipine, a new dihydropyridine calcium antagonist, in the treatment of hypertension.
    Leonetti G
    J Cardiovasc Pharmacol; 1991; 18 Suppl 11():S18-21. PubMed ID: 1725445
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative study of lacidipine and nifedipine SR in the treatment of hypertension: an Italian multicenter study. The Northern Italian Study Group of Lacidipine in Hypertension.
    Leonetti G
    J Cardiovasc Pharmacol; 1991; 17 Suppl 4():S31-4. PubMed ID: 1726003
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A long-term study comparing lacidipine and nifedipine SR in hypertensive patients: safety data.
    Leonetti G; Salvi S
    J Cardiovasc Pharmacol; 1994; 23 Suppl 5():S108-10. PubMed ID: 7609496
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Additive hypotensive effect of a dihydropyridine calcium antagonist to that produced by a thiazide diuretic: a double-blind placebo-controlled crossover trial with ambulatory blood pressure monitoring.
    Stergiou GS; Malakos JS; Achimastos AD; Mountokalakis TD
    J Cardiovasc Pharmacol; 1997 Mar; 29(3):412-6. PubMed ID: 9125681
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of a third generation calcium antagonist in the management of hypertension.
    Epstein M
    Drugs; 1999; 57 Suppl 1():1-10. PubMed ID: 10529076
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A double-blind comparison of the efficacy and safety of lacidipine with atenolol in the treatment of essential hypertension. The United Kingdom Lacidipine Study Group.
    J Cardiovasc Pharmacol; 1991; 17 Suppl 4():S27-30. PubMed ID: 1726002
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Radial artery compliance in essential hypertension: effects of antihypertensive therapy with lacidipine.
    Trazzi S; Santucciu C; Mancia G
    J Hypertens Suppl; 1993 Dec; 11(6):S17-20. PubMed ID: 8169377
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lacidipine, hydrochlorothiazide and their combination in systolic hypertension in the elderly.
    Wing LM; Arnolda LF; Harvey PJ; Upton J; Molloy D; Bune AJ; Chalmers JP
    J Hypertens; 1997 Dec; 15(12 Pt 1):1503-10. PubMed ID: 9431858
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Safety aspects of treatment with lacidipine--a slow-onset, long-acting calcium antagonist.
    Lindholm LH; Tcherdakoff P; Zanchetti A
    Blood Press; 1996 Jul; 5(4):241-9. PubMed ID: 8809376
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term antihypertensive treatment with lacidipine, a new long-acting calcium antagonist.
    Nami R; Rizzini P; Buracchi P; Pavese G; Gennari C
    J Cardiovasc Pharmacol; 1991; 18 Suppl 11():S22-5. PubMed ID: 1725446
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A double-blind comparison of the efficacy and safety of lacidipine and hydrochlorothiazide in essential hypertension. The Southern Italy Lacidipine Study Group.
    Chiariello M
    J Cardiovasc Pharmacol; 1991; 17 Suppl 4():S35-7. PubMed ID: 1726004
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Safety profile of lacidipine: a review of clinical data.
    Endersby CA; Brown EG; Perelman MS
    J Cardiovasc Pharmacol; 1991; 17 Suppl 4():S45-7. PubMed ID: 1726006
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The cardiac and vascular effects of lacidipine.
    Agabiti-Rosei E
    J Cardiovasc Pharmacol; 1995; 25 Suppl 3():S1-5. PubMed ID: 8852537
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative evaluation of the antihypertensive efficacy of once-daily sustained-release isradipine and lacidipine using 24-hour ambulatory blood-pressure monitoring.
    Galderisi M; Petrocelli A; Garofalo M; Celentano A; Alfieri A; de Divitiis O
    J Int Med Res; 1995; 23(4):234-43. PubMed ID: 7589766
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Preclinical study of the action of a calcium channel blocker during salt load].
    Godfraind T; Salomone S; Morel N; Ghisdal P
    Bull Acad Natl Med; 1997 Feb; 181(2):289-98; discussion 299-300. PubMed ID: 9235228
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.